Common Stock, $0.50 par value
- Symbol
- TRNS
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 5.07 · 8-K
Transcat, Inc.
TRNSNASDAQEQUITYCurrent
Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. At the annual meeting of shareholders of the Company held on September 9, 2026, the Company's shareholders voted on the matters described below: Proposal 1: The Company's shareholders elected the following nominees as directors, each to serve for a one-year term expiring in 2027 or until his or her successor is duly elected and qualified:…
Company context
Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its Calibration Service Centers strategically located across the United States and Internationally. In addition, Transcat operates calibration labs in imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Current securities
Registered securities in this filing
Transcat, Inc. · 8-K · Filed 2026-09-10
Disclosure sections
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07 Submission of Matters to a Vote of Security Holders.
At the annual meeting of shareholders of the Company held on September 9, 2026, the Company's shareholders voted on the matters described below:
Proposal 1: The Company's shareholders elected the following nominees as directors, each to serve for a one-year term expiring in 2027 or until his or her successor is duly elected and qualified:
Director Nominee Votes For Authority Withheld Broker Non-Votes
────────────────────────────────────────────────────────────────────────────────────────
Dawn G. DePerrior 7,970,329 108,427 614,849
Christopher P. Gillette 7,933,860 144,896 614,849
Gary J. Haseley 7,982,073 96,683 614,849
Mbago M. Kaniki 7,837,448 241,308 614,849
Cynthia M. Langston 8,007,300 71,456 614,849
Robert L. Mecca 8,056,315 22,441 614,849
Proposal 2: The Company's shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers:
Votes For Votes Against Votes Abstained Broker Non-Votes
───────────────────────────────────────────────────────────────────────────
7,921,274 153,061 4,421 614,849
Proposal 3: The Company's shareholders ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 27, 2027:
Votes For Votes Against Votes Abstained
─────────────────────────────────────────────────────
8,692,380 868 357